NPI: 1053343442 · MILWAUKEE, WI 53211 · Clinical Medical Laboratory · NPI assigned 07/07/2006
Authorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | MCCULLOUGH, MICHAEL (CFO) |
| NPI Enumeration Date | 07/07/2006 |
Other providers sharing the same authorized official: MCCULLOUGH, MICHAEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 80,849 | $1.26M |
| 2019 | 77,288 | $1.06M |
| 2020 | 75,430 | $1.04M |
| 2021 | 93,122 | $822K |
| 2022 | 102,687 | $1.18M |
| 2023 | 45,017 | $431K |
| 2024 | 7,834 | $12K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 16,067 | 14,616 | $489K |
| 80050 | General health panel | 13,106 | 10,793 | $484K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 16,040 | 14,596 | $467K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 14,208 | 12,768 | $417K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13,890 | 12,444 | $297K |
| 80061 | Lipid panel | 27,882 | 25,199 | $287K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,483 | 3,683 | $283K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 9,868 | 8,947 | $219K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,664 | 4,163 | $193K |
| 80053 | Comprehensive metabolic panel | 25,060 | 22,418 | $192K |
| 84443 | Thyroid stimulating hormone (TSH) | 16,320 | 14,606 | $182K |
| 83036 | Hemoglobin; glycosylated (A1C) | 22,624 | 20,515 | $161K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 5,444 | 4,986 | $156K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,721 | 5,969 | $131K |
| 82607 | 9,237 | 8,386 | $117K | |
| 86481 | 1,432 | 1,290 | $101K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,501 | 17,104 | $95K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2,315 | 2,191 | $87K |
| 86780 | 8,207 | 7,397 | $65K | |
| 86803 | 5,533 | 4,964 | $64K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,961 | 8,594 | $64K |
| 87653 | 1,730 | 1,610 | $58K | |
| 85027 | 11,229 | 9,915 | $57K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,873 | 2,129 | $56K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,547 | 7,551 | $56K |
| 84153 | 3,526 | 3,173 | $53K | |
| 82728 | 4,789 | 4,351 | $49K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 651 | 580 | $48K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,015 | 2,748 | $40K |
| 84439 | 5,247 | 4,756 | $38K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 157 | 139 | $38K |
| 82746 | 2,750 | 2,482 | $34K | |
| 83550 | 4,946 | 4,481 | $33K | |
| 80081 | 648 | 579 | $33K | |
| 82043 | 6,672 | 6,128 | $30K | |
| 86703 | 1,859 | 1,762 | $29K | |
| 81025 | 3,768 | 3,482 | $28K | |
| 83540 | 5,292 | 4,795 | $26K | |
| 87340 | 2,949 | 2,613 | $24K | |
| 82570 | 5,750 | 5,251 | $24K | |
| 87070 | 2,848 | 2,604 | $22K | |
| 87081 | 3,594 | 3,219 | $22K | |
| 81001 | 8,117 | 7,268 | $21K | |
| 86480 | 367 | 348 | $20K | |
| 84702 | 1,778 | 1,302 | $20K | |
| 87186 | 2,420 | 2,102 | $17K | |
| 81003 | 8,764 | 7,887 | $17K | |
| 86762 | 1,353 | 1,191 | $16K | |
| 84403 | 742 | 678 | $16K | |
| 83970 | 576 | 533 | $14K | |
| 86140 | 3,183 | 2,651 | $14K | |
| 85610 | 4,007 | 2,737 | $13K | |
| 87210 | 3,455 | 2,965 | $13K | |
| 84146 | 746 | 675 | $12K | |
| 83001 | 813 | 734 | $12K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 413 | 337 | $11K |
| 86235 | 962 | 239 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 325 | 298 | $10K |
| 87077 | 1,516 | 1,326 | $10K | |
| 80500 | 859 | 738 | $9K | |
| 83655 | 1,019 | 836 | $9K | |
| 82950 | 2,011 | 1,848 | $9K | |
| 86787 | 1,113 | 1,036 | $8K | |
| 82550 | 1,337 | 1,199 | $7K | |
| 80055 | 567 | 471 | $7K | |
| 36415 | Collection of venous blood by venipuncture | 70,272 | 61,617 | $7K |
| 85651 | 2,130 | 1,875 | $7K | |
| 86850 | 1,808 | 1,598 | $7K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 15 | 13 | $7K |
| 80076 | 1,077 | 963 | $7K | |
| 84550 | 1,908 | 1,713 | $7K | |
| 87147 | 1,442 | 1,222 | $6K | |
| 83735 | 1,086 | 949 | $6K | |
| 86706 | 680 | 618 | $6K | |
| 86038 | 639 | 578 | $5K | |
| 84481 | 408 | 382 | $5K | |
| 87088 | 703 | 633 | $5K | |
| 83516 | 469 | 327 | $5K | |
| 87634 | 94 | 83 | $5K | |
| 84460 | 1,110 | 960 | $5K | |
| 86431 | 932 | 858 | $5K | |
| 80074 | 169 | 153 | $5K | |
| 87252 | 119 | 117 | $4K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 697 | 553 | $3K |
| 99001 | 1,008 | 800 | $3K | |
| 83880 | 119 | 110 | $3K | |
| 83690 | 571 | 513 | $3K | |
| 84480 | 248 | 237 | $3K | |
| 85652 | 1,369 | 1,191 | $3K | |
| 86900 | 1,254 | 1,087 | $3K | |
| 86901 | 1,207 | 1,052 | $3K | |
| 86039 | 392 | 313 | $3K | |
| 84165 | 288 | 273 | $3K | |
| 86225 | 251 | 222 | $2K | |
| 84450 | 551 | 489 | $2K | |
| 82962 | 836 | 777 | $2K | |
| 83721 | 352 | 311 | $2K | |
| 83020 | 403 | 363 | $2K | |
| 86003 | 34 | 24 | $2K | |
| 86200 | 194 | 175 | $2K | |
| 86704 | 193 | 182 | $2K | |
| 87075 | 213 | 191 | $2K | |
| 83615 | 343 | 306 | $2K | |
| 83002 | 115 | 90 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 82 | 72 | $1K |
| 86765 | 93 | 88 | $1K | |
| 82565 | 370 | 315 | $1K | |
| 87205 | 336 | 305 | $1K | |
| 82784 | 114 | 103 | $1K | |
| 85007 | 418 | 375 | $1K | |
| 84156 | 346 | 308 | $944.30 | |
| 86160 | 149 | 70 | $929.76 | |
| 82670 | 44 | 40 | $887.10 | |
| 82947 | 247 | 199 | $753.57 | |
| 85018 | 364 | 327 | $714.02 | |
| 84402 | 32 | 28 | $664.50 | |
| 82785 | 39 | 27 | $541.69 | |
| 84270 | 30 | 26 | $523.47 | |
| 85730 | 142 | 127 | $467.39 | |
| 85014 | 241 | 206 | $439.87 | |
| Q0112 | All potassium hydroxide (koh) preparations | 78 | 63 | $374.43 |
| 82465 | 79 | 73 | $371.72 | |
| 88141 | 32 | 32 | $366.19 | |
| 85379 | 44 | 40 | $331.37 | |
| 86376 | 31 | 25 | $329.20 | |
| 84100 | 89 | 77 | $227.52 | |
| 84703 | 32 | 26 | $192.40 | |
| 84520 | 70 | 55 | $181.81 | |
| 87338 | 14 | 14 | $162.93 | |
| 87110 | 12 | 12 | $161.73 | |
| 88142 | 15 | 14 | $128.25 | |
| 86255 | 15 | 15 | $116.03 | |
| 86769 | 16 | 16 | $96.33 | |
| 88304 | 16 | 14 | $87.93 | |
| 85613 | 13 | 12 | $67.06 | |
| 85045 | 12 | 12 | $58.10 | |
| 84155 | 25 | 25 | $54.72 | |
| 85732 | 17 | 14 | $51.76 | |
| 87140 | 12 | 12 | $51.54 | |
| 99000 | 14 | 12 | $35.64 | |
| 81015 | 71 | 48 | $30.52 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 14 | 13 | $5.13 |
| 80361 | 267 | 223 | $0.00 | |
| 80365 | 489 | 381 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 136 | 65 | $0.00 |
| 80354 | 22 | 13 | $0.00 |